The Puerto Rico Asthma Integrated Response Program ("PR-AIR")
ConditionPediatric Asthma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-12
SponsorRhode Island Hospital
About this trial
The purpose of this study is to adapt and deliver an evidence-based multi-level intervention to reduce asthma disparities, and that promote and improve population health in the high-burden communities of San Juan, Puerto Rico.
The Puerto Rico-Asthma Integrated Response Program (PR-AIR) will be implemented and evaluated to address pediatric asthma disparities in San Juan, PR, an area of high asthma burden. This study unfolds in two phases: In Phase 1, the researchers will collaborate with community stakeholders to identify needs, barriers and facilitators of PR-AIR implementation. Phase 2 consists of an evaluation of low-intensity (virtual) and high-intensity (in-person) methods of PR-AIR implementation outcomes using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework and a mixed methods approach.
Eligibility criteria
Qualifiers
Children between the ages of 2 and 12 years old
Children must reside in one of the identified catchment areas
Children must meet the screening criteria as having not well controlled or poorly controlled asthma
Disqualifiers
None
Trial design
Treatments tested in this trial
- CASE in person version (High Intensity Package)
- CASE-V remote version (Low Intensity Package)
- CASE and HARP in person (High Intensity package)
- CASE-V and HARP-V remote version (Low Intensity package)
Treatment groups
480 Participants
are divided into 2 treatment groupsSponsors and collaborators
Rhode Island Hospital
Lead sponsor
University of Puerto Rico
Collaborator
Source ClinicalTrials.gov